Peer-reviewed veterinary case report
Inflammation and blood clot markers in overweight and obese dogs
By Barić Rafaj, R et al.·Published in BMC veterinary research·2017·Department of Chemistry and Biochemistry·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Plasma markers of inflammation and hemostatic and endothelial activity in naturally overweight and obese dogs.
- Species:
- dog
Plain-English summary
A study found that overweight and obese dogs had higher levels of certain inflammation markers in their blood compared to dogs of normal weight. Specifically, these dogs showed increased levels of interleukin-6 and C-reactive protein, which are signs of inflammation, as well as changes in blood clotting factors. While these changes indicate a state of chronic low-grade inflammation and increased risk of blood clotting, the study concluded that obesity does not seem to affect the function of blood vessels in dogs. Maintaining a healthy weight is important for reducing these health risks.
People also search for: dog obesity health risks · overweight dog inflammation · how to help my dog lose weight
Abstract
BACKGROUND: Obesity is one of the most prevalent health problems in the canine population. While haemostatic parameters and markers of endothelial function have been evaluated in various disease conditions in dogs, there are no studies of these markers in canine obesity. This study was designed to evaluate the effect of naturally gained weight excess and obesity on inflammatory, hemostatic and endothelial biomarkers in dogs. A total of 37 overweight and obese dogs were compared with 28 normal weight dogs. RESULTS: Overweight and obese dogs had significantly elevated concentrations of serum interleukin-6 (IL-6) and C-reactive protein (hsCRP). Number of platelets, activity of factor X and factor VII were significantly higher, while activated partial thromboplastine time (aPTT) and soluble plasminogen activator receptor (suPAR) were significantly decreased. Statistical analysis of high mobility group box - 1 protein (HMGB-1), soluble intercellular adhesive molecule -1 (sICAM-1) and plasminogen activator inhibitor type 1 (PAI-1) concentrations did not show significant differences between the total overweight and obese group and the normal weight group of dogs. CONCLUSIONS: Analytical changes in the dogs in our study reflects that weight excess in dogs can be associated with a chronic low degree of inflammation and a hypercoagulable state, where primary and secondary hemostasis are both affected. However obesity is not associated with impairment of endothelial function in dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/28061787/